Top

Published in:

18-01-2023 | Heart Failure | Original Paper

Adverse cardiovascular and metabolic perturbations among older women: ‘fat-craving’ hearts

Authors: Jien Sze Ho, Jie Jun Wong, Fei Gao, Hai Ning Wee, Louis L. Y. Teo, See Hooi Ewe, Ru-San Tan, Jianhong Ching, Kee Voon Chua, Lye Siang Lee, Woon-Puay Koh, Jean-Paul Kovalik, Angela S. Koh

Published in: Clinical Research in Cardiology | Issue 11/2023

Abstract

Background

Despite known sex-based differences in cardiovascular aging, differences in aging biology are poorly understood. We hypothesize that circulating metabolites studied cross-sectionally with cardiac aging may be associated with cardiovascular changes that distinguish cardiac aging in women.

Methods

A population-based cohort of community men and women without cardiovascular disease from Singapore underwent detailed clinical and echocardiography examinations. Cross-sectional associations between cardiac functional characteristics and metabolomics profiles were examined.

Results

Five hundred sixty-seven adults (48.9% women) participated. Women were younger (72 ± 4.4 years vs 73 ± 4.3 years, p = 0.022), had lower diastolic blood pressures (71 ± 11.0 mmHg vs 76 ± 11.2 mmHg, p < 0.0001, and less likely to have diabetes mellitus (18.0% vs 27.6%, p = 0.013) and smoking (3.8% vs 34.5%, p < 0.001). Body mass indices were similar (24 ± 3.8 kg/m² vs 24 ± 3.4 kg/m², p = 0.29), but women had smaller waist circumferences (81 ± 10.1 cm vs 85 ± 9.2 cm, p < 0.001). Women had a significantly higher E/e′ ratios (10.9 ± 3.4 vs 9.9 ± 3.3, p = 0.007) and mitral A peak (0.86 ± 0.2 m/s vs 0.79 ± 0.2 m/s, p < 0.001) than men. Among women, lower E/e′ ratio was associated with higher levels of C16 (OR 1.019, 95%CI 1.002–1.036, p = 0.029), C16:1 (OR 1.06, 95%CI 1.006–1.118, p = 0.028), serine (OR 1.019, 95%CI 1.002–1.036, p = 0.025), and histidine (OR 1.045, 95%CI 1.013–1.078, p = 0.006). Lower mitral A peak was associated with higher levels of histidine (OR 1.039, 95%CI 1.009–1.070, p = 0.011), isoleucine (OR 1.013, 95%CI 1.004–1.021, p = 0.004), and C20 (OR 1.341, 95%CI 1.067–1.684, p = 0.012).

Conclusion

Impairments in diastolic functions were more frequent among older women compared to men, despite lower prevalence of vascular risk factors and preserved cardiac structure. Cardiac aging in women correlated with metabolites involved in fatty acid oxidation and tricyclic acid cycle fuelling.

Merz AA, Cheng S (2016) Sex differences in cardiovascular ageing. Heart 102(11):825. https://doi.org/10.1136/heartjnl-2015-308769CrossRefPubMed

Hayward CS, Kelly RP, Collins P (2000) The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 46(1):28–49. https://doi.org/10.1016/s0008-6363(00)00005-5CrossRefPubMed

Swaraj S, Kozor R, Arnott C, Di Bartolo BA, Figtree GA (2021) Heart failure with reduced ejection fraction-does sex matter? Curr Heart Fail Rep 18(6):345–352. https://doi.org/10.1007/s11897-021-00533-yCrossRefPubMedPubMedCentral

Oktay AA, Rich JD, Shah SJ (2013) The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep 10(4):401–410. https://doi.org/10.1007/s11897-013-0155-7CrossRefPubMed

Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA (2005) Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 112(15):2254–2262. https://doi.org/10.1161/CIRCULATIONAHA.105.541078CrossRefPubMed

Pauls SD et al (2021) Impact of age, menopause, and obesity on oxylipins linked to vascular health. Arterioscler Thromb Vasc Biol 41(2):883–897. https://doi.org/10.1161/ATVBAHA.120.315133CrossRefPubMed

Huang T et al (2019) Habitual sleep quality, plasma metabolites and risk of coronary heart disease in post-menopausal women. Int J Epidemiol 48(4):1262–1274. https://doi.org/10.1093/ije/dyy234CrossRefPubMed

Campesi I et al (2016) Ageing/menopausal status in healthy women and ageing in healthy men differently affect cardiometabolic parameters. Int J Med Sci 13(2):124–132. https://doi.org/10.7150/ijms.14163CrossRefPubMedPubMedCentral

Auro K et al (2014) A metabolic view on menopause and ageing. Nat Commun 5(1):4708. https://doi.org/10.1038/ncomms5708CrossRefPubMed

10.

Shah SH, Newgard CB (2015) Integrated metabolomics and genomics. Circ Cardiovasc Genet 8(2):410–419. https://doi.org/10.1161/CIRCGENETICS.114.000223CrossRefPubMedPubMedCentral

11.

Fujimoto N et al (2012) Effect of ageing on left ventricular compliance and distensibility in healthy sedentary humans. J Physiol 590(8):1871–1880. https://doi.org/10.1113/jphysiol.2011.218271CrossRefPubMedPubMedCentral

12.

Shah SJ et al (2020) Research priorities for heart failure with preserved ejection fraction. Circulation 141(12):1001–1026. https://doi.org/10.1161/CIRCULATIONAHA.119.041886CrossRefPubMedPubMedCentral

13.

Vogel MW, Slusser JP, Hodge DO, Chen HH (2012) The natural history of preclinical diastolic dysfunction: a population-based study. Circ Heart Fail 5(2):144–151. https://doi.org/10.1161/CIRCHEARTFAILURE.110.959668CrossRefPubMedPubMedCentral

14.

Strait JB, Lakatta EG (2012) Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin 8(1):143–164. https://doi.org/10.1016/j.hfc.2011.08.011CrossRefPubMedPubMedCentral

15.

From AM, Scott CG, Chen HH (2010) The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol 55(4):300–305. https://doi.org/10.1016/j.jacc.2009.12.003CrossRefPubMed

16.

Kovalik JP et al (2021) Amino acid differences between diabetic older adults and non-diabetic older adults and their associations with cardiovascular function. J Mol Cell Cardiol 158:63–71. https://doi.org/10.1016/j.yjmcc.2021.05.009CrossRefPubMed

17.

Hankin JH et al (2001) Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer 39(2):187–195. https://doi.org/10.1207/S15327914nc392_5CrossRefPubMed

18.

Denchev SV, Simova II, Matveev MG (2007) Evaluation of the SCHILLER BR-102 plus noninvasive ambulatory blood pressure monitor according to the International Protocol introduced by the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Blood Press Monit 12(5):329–333. https://doi.org/10.1097/MBP.0b013e32813fa39eCrossRefPubMed

19.

Nes BM, Janszky I, Vatten LJ, Nilsen TI, Aspenes ST, Wisløff U (2011) Estimating V·O 2peak from a nonexercise prediction model: the HUNT Study, Norway. Med Sci Sports Exerc 43(11):2024–2030. https://doi.org/10.1249/MSS.0b013e31821d3f6fCrossRefPubMed

20.

Nes BM, Vatten LJ, Nauman J, Janszky I, Wisløff U (2014) A simple nonexercise model of cardiorespiratory fitness predicts long-term mortality. Med Sci Sports Exerc 46(6):1159–1165. https://doi.org/10.1249/mss.0000000000000219CrossRefPubMed

21.

Koh AS et al (2018) Metabolomic correlates of aerobic capacity among elderly adults. Clin Cardiol 41(10):1300–1307. https://doi.org/10.1002/clc.23016CrossRefPubMedPubMedCentral

22.

Lang RM et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1–39. https://doi.org/10.1016/j.echo.2014.10.003CrossRefPubMed

23.

Gao F et al (2021) Exacerbation of cardiovascular ageing by diabetes mellitus and its associations with acyl-carnitines. Aging 13(11):14785–14805. https://doi.org/10.18632/aging.203144CrossRefPubMedPubMedCentral

24.

Upadhya B, Kitzman DW (2017) Heart failure with preserved ejection fraction in older adults. Heart Fail Clin 13(3):485–502. https://doi.org/10.1016/j.hfc.2017.02.005CrossRefPubMedPubMedCentral

25.

Kobak KA, Zarzycka W, Chiao YA (2022) Age and sex differences in heart failure with preserved ejection fraction. Front Aging. https://doi.org/10.3389/fragi.2022.811436CrossRefPubMedPubMedCentral

26.

Paulus WJ et al (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28(20):2539–2550CrossRefPubMed

27.

Eaton CB et al (2016) Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women. Circ Heart Fail. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002883CrossRefPubMedPubMedCentral

28.

Hunter WG et al (2016) Metabolomic profiling identifies novel circulating biomarkers of mitochondrial dysfunction differentially elevated in heart failure with preserved versus reduced ejection fraction: evidence for shared metabolic impairments in clinical heart failure. J Am Heart Assoc. https://doi.org/10.1161/jaha.115.003190CrossRefPubMedPubMedCentral

29.

Cheng ML et al (2015) Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. J Am Coll Cardiol 65(15):1509–1520. https://doi.org/10.1016/j.jacc.2015.02.018CrossRefPubMed

30.

Koh AS et al (2018) Dissecting clinical and metabolomics associations of left atrial phasic function by cardiac magnetic resonance feature tracking. Sci Rep 8(1):8138–8138. https://doi.org/10.1038/s41598-018-26456-8CrossRefPubMedPubMedCentral

31.

Rinaldo P, Cowan TM, Matern D (2008) Acylcarnitine profile analysis. Genet Med 10(2):151–156. https://doi.org/10.1097/GIM.0b013e3181614289CrossRefPubMed

32.

Makrecka-Kuka M et al (2017) Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues. Sci Rep 7(1):17528. https://doi.org/10.1038/s41598-017-17797-xCrossRefPubMedPubMedCentral

33.

Molina AJ et al (2016) Skeletal muscle mitochondrial content, oxidative capacity, and Mfn2 expression are reduced in older patients with heart failure and preserved ejection fraction and are related to exercise intolerance. JACC Heart Fail 4(8):636–645. https://doi.org/10.1016/j.jchf.2016.03.011CrossRefPubMedPubMedCentral

34.

Rutkowsky JM et al (2014) Acylcarnitines activate proinflammatory signaling pathways. Am J Physiol Endocrinol Metab 306(12):E1378–E1387. https://doi.org/10.1152/ajpendo.00656.2013CrossRefPubMedPubMedCentral

35.

Koh A et al (2017) Metabolomic profile of arterial stiffness in aged adults. Diab Vasc Dis Res 15:147916411773362. https://doi.org/10.1177/1479164117733627CrossRef

36.

van der Zwaard S et al (2016) Maximal oxygen uptake is proportional to muscle fiber oxidative capacity, from chronic heart failure patients to professional cyclists. J Appl Physiol (1985) 121(3):636–645. https://doi.org/10.1152/japplphysiol.00355.2016CrossRefPubMed

37.

Betik AC, Hepple RT (2008) Determinants of VO2 max decline with aging: an integrated perspective. Appl Physiol Nutr Metab 33(1):130–140. https://doi.org/10.1139/h07-174CrossRefPubMed

38.

Magkos F et al (2013) Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on branched-chain amino acid metabolism. Diabetes 62(8):2757–2761. https://doi.org/10.2337/db13-0185CrossRefPubMedPubMedCentral

39.

Chng CL et al (2016) Physiological and metabolic changes during the transition from hyperthyroidism to euthyroidism in graves’ disease. Thyroid 26(10):1422–1430. https://doi.org/10.1089/thy.2015.0602CrossRefPubMed

40.

Bao XR et al (2016) Mitochondrial dysfunction remodels one-carbon metabolism in human cells. Elife. https://doi.org/10.7554/eLife.10575CrossRefPubMedPubMedCentral

41.

Razavi AC et al (2020) Novel findings from a metabolomics study of left ventricular diastolic function: the Bogalusa heart study. J Am Heart Assoc 9(3):e015118. https://doi.org/10.1161/JAHA.119.015118CrossRefPubMedPubMedCentral

42.

Previtali M, Chieffo E, Ferrario M, Klersy C (2012) Is mitral E/E′ ratio a reliable predictor of left ventricular diastolic pressures in patients without heart failure? European Heart Journal - Cardiovascular Imaging 13(7):588–595. https://doi.org/10.1093/ejechocard/jer286CrossRefPubMed

43.

Sharp AS et al (2010) Tissue Doppler E/E’ ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy. Eur Heart J 31(6):747–752. https://doi.org/10.1093/eurheartj/ehp498CrossRefPubMed

44.

Kim HL et al (2013) The association between arterial stiffness and left ventricular filling pressure in an apparently healthy Korean population. Cardiovasc Ultrasound 11(1):2. https://doi.org/10.1186/1476-7120-11-2CrossRefPubMedPubMedCentral

45.

H-L Kim et al (2017) Association between arterial stiffness and left ventricular diastolic function in relation to gender and age. Medicine 96(1) [Online]. https://journals.lww.com/md-journal/Fulltext/2017/01060/Association_between_arterial_stiffness_and_left.47.aspx.

46.

Wu J, Yu SY, Wo D, Zhao MM, Zhang LJ, Li J (2016) Risks and predictors of mild diastolic dysfunction among middle-aged and aged women: a population-based cohort study. J Hum Hypertens 30(5):335–340. https://doi.org/10.1038/jhh.2015.85CrossRefPubMed

47.

Zhao Z, Wang H, Jessup JA, Lindsey SH, Chappell MC, Groban L (2014) Role of estrogen in diastolic dysfunction. American Journal of Physiology-Heart and Circulatory Physiology 306(5):H628–H640. https://doi.org/10.1152/ajpheart.00859.2013CrossRefPubMedPubMedCentral

48.

Mathew S et al (2014) Metabolomics of Ramadan fasting: an opportunity for the controlled study of physiological responses to food intake. J Transl Med 12:161. https://doi.org/10.1186/1479-5876-12-161CrossRefPubMedPubMedCentral

49.

Carayol M et al (2015) Reliability of serum metabolites over a two-year period: a targeted metabolomic approach in fasting and non-fasting samples from EPIC. PLoS ONE 10(8):e0135437. https://doi.org/10.1371/journal.pone.0135437CrossRefPubMedPubMedCentral

50.

Hancox RJ, Landhuis CE (2011) Correlation between measures of insulin resistance in fasting and non-fasting blood. Diabetol Metab Syndr 3(1):23. https://doi.org/10.1186/1758-5996-3-23CrossRefPubMedPubMedCentral

51.

Wallace TM, Matthews DR (2002) The assessment of insulin resistance in man. Diabet Med. https://doi.org/10.1046/j.1464-5491.2002.00745.xCrossRefPubMed

Title: Adverse cardiovascular and metabolic perturbations among older women: ‘fat-craving’ hearts
Authors: Jien Sze Ho
Jie Jun Wong
Fei Gao
Hai Ning Wee
Louis L. Y. Teo
See Hooi Ewe
Ru-San Tan
Jianhong Ching
Kee Voon Chua
Lye Siang Lee
Woon-Puay Koh
Jean-Paul Kovalik
Angela S. Koh
Publication date: 18-01-2023
Publisher: Springer Berlin Heidelberg
Keyword: Heart Failure
Published in: Clinical Research in Cardiology / Issue 11/2023
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-023-02156-w

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Adverse cardiovascular and metabolic perturbations among older women: ‘fat-craving’ hearts

Abstract

Background

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2023

Acute exposure to simulated nocturnal traffic noise and cardiovascular complications and sleep disturbance—results from a pooled analysis of human field studies

A meta-analysis evaluating efficacy and safety of colchicine for prevention of major cardiovascular events in patients with coronary artery disease

Added value of arterial stiffness index for the 10-year atherosclerotic cardiovascular disease risk determination in a middle-aged population-based study

Age period cohort analysis of rheumatic heart disease in high-income countriess

Physical exercise as a treatment for persisting symptoms post-COVID infection: review of ongoing studies and prospective randomized controlled training study

Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page